AASCIN.ORG

AASCIN

Position Statements  3

Prevention of Transmission of Blood Borne Pathogens

BACKGROUND
The transmission of blood borne pathogens (HBV, HIV) has brought to the forefront questions of testing, disclosure, and continued practice for health care workers. Many professional organizations are preparing consensus statements bearing on issues related to health care workers who are, or may be, infected by the human immunodeficiency virus. AASCIN wishes to comment on this important issue.

DEFINITIONS
HBV - Hepatitis B virus (previously called serum hepatitis)

HIV - Human Immunodeficiency virus

HCW - Any professional person providing health care

Blood Borne Pathogen - Refers to blood or other hazardous body fluids (those containing visible blood) that can transmit pathogens.

POSITION
AASCIN continues to advocate the highest quality of care for all patients and the protection of the civil and human rights of all persons with HIV/HBV infection.

AASCIN supports the Centers for Disease Control (CDC) recommendations for Prevention of HIV and HBV transmission in health care settings which emphasizes the need to treat blood and body fluids from all patients as potentially infectious. This approach is referred to as universal precautions.

Adherence to CDC guidelines on universal precautions will minimize the risk of transmission of HBV, HIV, and other blood borne pathogens.

Research data indicate that prevention of transmission of HIV/HBV infection from health care workers is best accomplished by strict adherence to infection control procedure and implementation of universal precautions. Disclosure of HIV status does not in itself prevent the transmission of blood borne infections.

(adopted 9/91)

 


About AASCIN Call for Awards Legislative Update Position Statements
Annual Conference Call for Papers & Posters Links Publications
Board of Directors Call for Research Listserv Contact Us
By Laws Committees Membership Home